ISSN : 2146-3123
E-ISSN : 2146-3131

Hepatitis B and Hepatitis C Seroprevalence in the Center of Sanliurfa Province From Southeastern Anatolia Region and Related Risk Factors
Süda Tekin Koruk 1, Bensu Gürsoy 1, Celal Çalışır 1, İbrahim Koruk 2, Zeynep Şimşek 2, Fehmi Yüksel 3, Fadile Yıldız Seyrek 4
1Harran University School of Medicine, Department of 1Infectious Diseases and Clinical Microbiology, Sanliurfa
2Harran University School of Medicine, Department of Public Health, Sanliurfa
3Harran University School of Medicine, Department of Microbiology and Clinical Microbiology,Sanliurfa
4Department of Microbiology, Faculty of Medicine, Harran University, Şanlıurfa, Turkey
DOI : 10.5174/tutfd.2009.02533.0
Pages : 367-372


Objective: The aim of this study was to evaluate the seroprevalence of HBV and HCV and related risk factors in Sanliurfa, a province of southeastern Anatolia.

Material and Methods: This cross-sectional study was conducted between April and May, 2008 in Sanliurfa's city center. A community-based representative sample (N=1070) was randomly selected using cluster sampling from the catchment areas served by 19 different primary healthcare centers. A questionnaire evaluating demographic information and probable risk factors for HBV and HCV was administered, and HBsAg and anti-HCV markers were analyzed from blood samples.

Results: Among the 1070 individuals who participated in the study, 33.1% were male (n=354) and 66.9% female (n=716). The average age was 35.4±13.5 (15-90) years. The seroprevalence of HBsAg positivity was 4.2% (n=45), while anti-HCV seropositivity was found to be 1.0% (n=11). Among participants who previously suffered a known hepatitis infection or who reported a family history of hepatitis, the HBsAg positivity was found to be higher (p<0.05). There was no statistically significant difference between HCV transmission risk factors and anti-HCV positivity.

Conclusion: This is the first hepatitis seroprevalence study in central Sanliurfa and demonstrated moderate HBV infection endemicity.

Keywords : HBsAg; Anti-HCV; seroprevalence; Sanliurfa

Viewed : 2069
Downloaded : 569